ClinConnect ClinConnect Logo
Search / Trial NCT06480942

Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Spontaneously Breathing Patients

Launched by CHU DE REIMS · Jun 25, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pulse Pressure Pulse Pressure Variation Passive Leg Raising Echocardiography Preload Dependency

ClinConnect Summary

This clinical trial is studying a method to help doctors determine if critically ill patients who are breathing on their own will benefit from receiving extra fluids. When patients are in septic shock, they often need fluids, but giving too much can be harmful if their heart isn't pumping enough blood. The researchers will look at specific measurements from patients' blood pressure and how their heart responds when they lift their legs for a minute. By comparing these measurements, they hope to identify which patients will respond positively to fluid treatment.

To participate in this study, patients must be over 18 years old and hospitalized in intensive care with signs of low blood pressure or other issues that suggest they may need fluids. They also need to be able to breathe without assistance and have a special catheter in place to monitor their blood pressure. However, patients with certain conditions, like irregular heartbeats or those who cannot lift their legs, are not eligible. If chosen for the trial, participants can expect to undergo some simple tests while being closely monitored to help doctors make better decisions about their treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient over 18 years old.
  • Hospitalized in intensive care.
  • * For which the clinician in charge of the patient will need to predict the response to fluids and decide on a possible infusion of fluids, because of:
  • Acute circulatory failure with mean arterial pressure \< 65mmHg or \< 30mmHg of its baseline value for hypertensive patients.
  • * And/or other signs of hemodynamic instability (tachycardia, mottling, oliguria, hyperlactatemia) :
  • In spontaneous ventilation and without ventilatory assistance.
  • Previously equipped with an arterial catheter.
  • Affiliated to a social security scheme.
  • Exclusion Criteria:
  • Patient with arrythmia (PPV is not applicable).
  • Patient with intra-abdominal hypertension (PLR test is not valid).
  • Patient with a contraindication/impossibility to the PLR maneuver (lower limb amputation, respiratory intolerance).
  • Patient with poor echogenicity noted previously.
  • Patient protected by law.

About Chu De Reims

Chu de Reims, or the University Hospital of Reims, is a leading healthcare institution in France dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent clinical trial sponsor, Chu de Reims focuses on a wide range of therapeutic areas, fostering collaboration between multidisciplinary teams of healthcare professionals and researchers. The hospital is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that all trials are designed to deliver reliable data while prioritizing patient safety and well-being. Through its robust research infrastructure, Chu de Reims aims to contribute significantly to the advancement of medical knowledge and the development of new treatment options.

Locations

Reims, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported